Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Carin Al Uyl-de Groot

Name: Cost-effectiveness of CAR T-cell therapy
Uploaded: 2020-02-12T16:40:36.000Z
Duration: 3 min 36 s
Description: Carin Al Uyl-de Groot, PhD, Erasmus University Rotterdam, Rotterdam, The Netherlands, discusses the evaluation of the cost-effectiveness of CAR T-cell therapy for pediatric acute lymphoblastic leukemia (ALL) and diffuse large B-cell lymphoma (DLBCL). This interview took place at the 2nd European CAR T-Cell Meeting in Sitges, Spain.

Sorry, no posts matched your criteria.

Carin Al Uyl-de Groot

Cookie settings